Vanderbilt-Ingram Cancer Center Archive — Page 16 of 28
-
August 18, 2022
Abramson, Eng, Johnson named to new VICC roles
Three physician researchers at Vanderbilt-Ingram Cancer Center are assuming additional leadership roles. -
August 17, 2022
Trial for colorectal cancer drug reaches primary endpoint
A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration has met its primary endpoint of overall survival in a phase 3 clinical trial. -
August 11, 2022
Cell-free breast cancer “biopsy”
The circulating DNA that tumors release is a reliable metric of tumor genomics and can be used to monitor molecular changes in metastatic breast cancer. -
August 11, 2022
Couple’s gift helps support immunotherapy research
Luke and Susan Simons have endowed a new directorship that will support research so that more people can benefit from immunotherapies. -
August 4, 2022
Female bladder cancer patients to benefit from new care support coordinator
A philanthropic gift of a patient care coordinator designated to assist female bladder cancer patients in education, clinical decision-making, surveillance, support and even screening, is the first of its kind at Vanderbilt University Medical Center. -
August 2, 2022
Targeted cancer drug during pregnancy
The targeted cancer therapy alectinib was safe as a treatment for lung cancer during two pregnancies in a patient with non-small cell lung cancer, according to a case report from Vanderbilt physicians. -
August 1, 2022
H. pylori and lung cancer
Specific biomarkers for H. pylori — a bacterium that infects the stomach — were associated with increased risk of lung cancer, Vanderbilt researchers have discovered.